Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 168 Myelodysplastic Syndromes 75 Leukemia 37 Leukemia, Myelomonocytic, Chronic 35 Recurrence 22 Myeloproliferative Disorders 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Congenital Abnormalities 12 Lymphoma, Large B-Cell, Diffuse 11 Primary Myelofibrosis 8 Neoplasms 8 Blast Crisis 8 Thrombocythemia, Essential 7 Polycythemia Vera 7 Leukemia, Monocytic, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myelodysplastic-Myeloproliferative Diseases 6 Melanoma 6 Leukemia, Myelomonocytic, Acute 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Hodgkin Disease 6 Anemia, Refractory, with Excess of Blasts 6 Ovarian Neoplasms 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Biphenotypic, Acute 5 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Lung Neoplasms 4

Interventions

pembrolizumab 23 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 Interleukin-2 15 fludarabine 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Surgical Procedures, Operative 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 encorafenib 4 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00715793 2017-10-03

UPCI-07-008

University of Pittsburgh

Phase 1/2 Completed

39 enrolled 12 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡